A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma
Clinical trial NCT02908672 · COMPLETED
Trial details
- NCT number
- NCT02908672
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2019-10-11
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.